Los Angeles Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Sell |
33,122
-22,676
| -41% | -$404K | ﹤0.01% | 807 |
|
|
2025
Q1 | $994K | Sell |
55,798
-14,803
| -21% | -$264K | ﹤0.01% | 566 |
|
|
2024
Q4 | $2.1M | Buy |
70,601
+55,334
| +362% | +$1.65M | 0.01% | 440 |
|
|
2024
Q3 | $239K | Buy |
+15,267
| New | +$239K | ﹤0.01% | 1080 |
|
|
2021
Q3 | – | Sell |
-1,529
| Closed | -$339K | – | 1557 |
|
|
2021
Q2 | $339K | Sell |
1,529
-5,829
| -79% | -$1.29M | ﹤0.01% | 1347 |
|
|
2021
Q1 | $973K | Sell |
7,358
-20,095
| -73% | -$2.66M | ﹤0.01% | 908 |
|
|
2020
Q4 | $4.75M | Sell |
27,453
-21,515
| -44% | -$3.72M | 0.02% | 405 |
|
|
2020
Q3 | $5.45M | Sell |
48,968
-145,955
| -75% | -$16.2M | 0.03% | 349 |
|
|
2020
Q2 | $11.6M | Buy |
194,923
+138,595
| +246% | +$8.22M | 0.06% | 252 |
|
|
2020
Q1 | $3.79M | Buy |
56,328
+35,545
| +171% | +$2.39M | 0.02% | 388 |
|
|
2019
Q4 | $1.75M | Buy |
20,783
+11,518
| +124% | +$970K | 0.01% | 680 |
|
|
2019
Q3 | $693K | Sell |
9,265
-12,534
| -57% | -$938K | ﹤0.01% | 904 |
|
|
2019
Q2 | $1.38M | Buy |
21,799
+500
| +2% | +$31.6K | 0.01% | 742 |
|
|
2019
Q1 | $1.03M | Buy |
+21,299
| New | +$1.03M | 0.01% | 848 |
|
|
2018
Q4 | – | Sell |
-36,244
| Closed | -$1.9M | – | 1346 |
|
|
2018
Q3 | $1.9M | Hold |
36,244
| – | – | 0.01% | 679 |
|
|
2018
Q2 | $1.13M | Buy |
+36,244
| New | +$1.13M | 0.01% | 854 |
|